Keros Therapeutics, Inc. was included in several Russell Value Indices as part of the annual rebalancing, effective June 30, 2025. The company was added to the Russell 3000 Value Index, Russell 2500 Value Index, Russell Small Cap Comp Value Index, and Russell 2000 Value Index.
Concurrently, Keros was removed from the corresponding Russell Growth Indices, including the Russell 3000 Growth Index, Russell Small Cap Comp Growth Index, Russell 2500 Growth Index, and Russell 2000 Growth Index. This reclassification indicates a shift in how the market perceives Keros' investment profile.
The move from growth to value indices reflects changes in the company's market capitalization and growth characteristics relative to other companies in the Russell universe. Such rebalancing can impact the composition of passively managed funds that track these indices.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.